ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells

Area of Science:

• Molecular Biology
• Cellular Signaling
• Cancer Research

Background:

• N-(4-hydroxyphenyl) retinamide (4-HPR), a synthetic retinoid, demonstrates anti-carcinogenic properties across various cancers.
• Reactive oxygen species (ROS) are recognized as key mediators in 4-HPR-induced apoptosis.
• The Akt signaling pathway's role in 4-HPR-mediated apoptosis requires further elucidation.

Purpose of the Study:

• To investigate the involvement of the Akt signaling pathway in 4-HPR-induced apoptosis.
• To explore the interplay between ROS and Akt in the context of 4-HPR treatment.
• To elucidate the molecular mechanisms underlying Akt regulation during 4-HPR-mediated apoptosis.

Main Methods:

• Cellular assays to assess apoptosis induction by 4-HPR.
• Analysis of Akt signaling pathway components, including PI3K, Akt, Hsp90, and PP2A.
• Measurement of ROS generation and assessment of antioxidant effects (N-acetylcysteine, glutathione).
• Investigation of Akt conformational changes and protein-protein interactions.

Main Results:

• 4-HPR induces apoptosis through a mechanism involving the Akt signaling pathway, independent of PI3K expression changes.
• ROS generated by 4-HPR directly induce a conformational change in Akt by forming an intramolecular disulfide bond.
• This ROS-evoked conformational change in Akt disrupts Akt-Hsp90 binding and enhances Akt-PP2A interaction, leading to Akt dephosphorylation.

Conclusions:

• 4-HPR-induced apoptosis is critically dependent on ROS-mediated alterations within the Akt signaling pathway.
• The study reveals a novel mechanism where ROS directly modify Akt's conformation, impacting its regulatory interactions.
• Targeting ROS or modulating Akt-Hsp90/Akt-PP2A interactions could represent therapeutic strategies in 4-HPR-treated cancers.